gene therapy
ADA-SCID
X-SCID
SCID patients
recombination deficient SCID
major types of SCID
common  group of SCID
common major category of SCID
SCID underlying recombination defects
therapeutic gene expression
Stem-cell
autologous  stem cell
multinational clinical trials
autologous hematopoietic stem cell
clinical reality
pre-GMP
GMP lentiviral batches
EU  global leader
orphan immune diseases
rare inherited immune disorders
successful previous EU consortia
regulatory authorities
input
design
novel safety assays
integration sites
logical extension
functional readouts
unmet medical need
patient advocacy groups
Stage
current proposal
higher complexities
affected genes
end
effective treatment
aim
Europe
RAG